{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:07:52Z","timestamp":1790615272207,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pnpbp.2017.06.023","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T01:31:46Z","timestamp":1498267906000},"page":"289-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"PB","title":["Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"79","author":[{"given":"Dian-Jeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Tao","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Sheng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-8487","authenticated-orcid":false,"given":"Han-Yung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0853","authenticated-orcid":false,"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-4567","authenticated-orcid":false,"given":"Pao-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Chik-keung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/070674370605100102","article-title":"Do many patients with depression suffer from bipolar disorder?","volume":"51","author":"Angst","year":"2006","journal-title":"Can. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.06.023_bb0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.genhosppsych.2009.05.005","article-title":"Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials","volume":"31","author":"Arbaizar","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1092852900019489","article-title":"Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review","volume":"10","author":"Biederman","year":"2005","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0025","first-page":"CD005000","article-title":"Aripiprazole alone or in combination for acute mania","volume":"12","author":"Brown","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.06.023_bb0035","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-5618.2011.00974.x","article-title":"Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)","volume":"14","author":"Carlson","year":"2012","journal-title":"Bipolar Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2017.06.023_bb0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.genhosppsych.2010.09.005","article-title":"Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study","volume":"32","author":"Chien","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"9878","key":"10.1016\/j.pnpbp.2017.06.023_bb0050","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","article-title":"Genetics of bipolar disorder","volume":"381","author":"Craddock","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2288-11-160","article-title":"Characteristics of meta-analyses and their component studies in the cochrane database of systematic reviews: a cross-sectional, descriptive analysis","volume":"11","author":"Davey","year":"2011","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/11208320-000000000-00000","article-title":"Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder","volume":"72","author":"Dhillon","year":"2012","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.06.023_bb0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/hup.2535","article-title":"Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis","volume":"31","author":"Dundar","year":"2016","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/cvr\/cvu143","article-title":"High-density lipoprotein, beta cells, and diabetes","volume":"103","author":"von Eckardstein","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"7109","key":"10.1016\/j.pnpbp.2017.06.023_bb0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.pnpbp.2017.06.023_bb0085","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.euroneuro.2010.07.003","article-title":"A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)","volume":"20","author":"El Mallakh","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2011.11.043","article-title":"A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder","volume":"136","author":"El-Mallakh","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.pnpbp.2017.06.023_bb0095","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study","volume":"70","author":"Findling","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4088\/JCP.11m07104","article-title":"Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder","volume":"73","author":"Findling","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bdi.12042","article-title":"Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study","volume":"15","author":"Findling","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1744-859X-8-27","article-title":"Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis","volume":"8","author":"Fountoulakis","year":"2009","journal-title":"Ann. General Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2010.10.018","article-title":"Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis","volume":"133","author":"Fountoulakis","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fphar.2016.00002","article-title":"Protective effects of HDL against ischemia\/reperfusion injury","volume":"7","author":"Gomaraschi","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.06.023_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euroneuro.2008.03.003","article-title":"ECNP consensus meeting. Bipolar depression. Nice, March 2007","volume":"18","author":"Goodwin","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2017.06.023_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"7414","key":"10.1016\/j.pnpbp.2017.06.023_bb0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4088\/JCP.v64n0209","article-title":"Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0b013e3182560401","article-title":"Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial","volume":"35","author":"Jeong","year":"2012","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2017.06.023_bb0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0327(02)00332-4","article-title":"The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases","volume":"73","author":"Judd","year":"2003","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/15622975.2012.669047","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study)","volume":"15","author":"Kanba","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0170","first-page":"1","article-title":"History of lifetime suicide attempt in bipolar I disorder: its correlates and effect on illness course","author":"Kattimani","year":"2016","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.pnpbp.2017.06.023_bb0180","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2017.06.023_bb0185","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2017.06.023_bb0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2017.06.023_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain","volume":"493","author":"Li","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.06.023_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jad.2017.02.012","article-title":"Maintenance therapy with second generation antipsychotics for bipolar disorder - a systematic review and meta-analysis","volume":"213","author":"Lindstrom","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-5618.2011.00887.x","article-title":"Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design","volume":"13","author":"van der Loos","year":"2011","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1399-5618.2011.00898.x","article-title":"Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study","volume":"13","author":"Marcus","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0220","doi-asserted-by":"crossref","DOI":"10.1159\/000453272","article-title":"Psychosocial factors and comorbidity associated with suicide attempts: findings in patients with bipolar disorder","author":"McGrady","year":"2017","journal-title":"Psychopathology"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40263-013-0134-2","article-title":"Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder","volume":"28","author":"McKeage","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2015.11.033","article-title":"A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies","volume":"191","author":"Meduri","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.06.023_bb0240","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0245","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.06.023_bb0250","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1742-1241.2008.01735.x","article-title":"Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study","volume":"62","author":"Muzina","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.pnpbp.2017.06.023_bb0255","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1399-5618.2010.00856.x","article-title":"Self-esteem in remitted bipolar disorder patients: a meta-analysis","volume":"12","author":"Nilsson","year":"2010","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.bp.114.157123","article-title":"Psychological interventions for adults with bipolar disorder: systematic review and meta-analysis","volume":"208","author":"Oud","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0265","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2147\/NDT.S91397","article-title":"Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Oya","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"7 Suppl","key":"10.1016\/j.pnpbp.2017.06.023_bb0270","first-page":"S178","article-title":"Treatment of bipolar disorder: the evolving role of atypical antipsychotics","volume":"13","author":"Perlis","year":"2007","journal-title":"Am. J. Manag. Care"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.06.023_bb0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials","volume":"67","author":"Perlis","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0280","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00002018-200528030-00002","article-title":"Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management","volume":"28","author":"Pierre","year":"2005","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0285","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hup.1096","article-title":"Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study","volume":"25","author":"Quante","year":"2010","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2017.06.023_bb0290","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.eurpsy.2010.01.001","article-title":"Work impairment in bipolar disorder patients\u2014results from a two-year observational study (EMBLEM)","volume":"25","author":"Reed","year":"2010","journal-title":"Eur. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.06.023_bb0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-0327(79)90010-7","article-title":"Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder","volume":"1","author":"Rosenthal","year":"1979","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.06.023_bb0300","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0305","series-title":"The American Psychiatric Publishing Textbook of Psychopharmacology","author":"Schatzberg","year":"2009"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.06.023_bb0310","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.64.4.442","article-title":"Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Scherk","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.06.023_bb0315","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","article-title":"Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials","volume":"9","author":"Smith","year":"2007","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0320","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1742-1241.2003.tb11397.x","article-title":"Aripiprazole: a review of its pharmacology and clinical use","volume":"57","author":"Taylor","year":"2003","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies","volume":"28","author":"Thase","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2017.06.023_bb0330","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archpsyc.1990.01810240026005","article-title":"Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis","volume":"47","author":"Tohen","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.06.023_bb0335","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1176\/appi.ajp.160.12.2099","article-title":"The McLean-Harvard first-episode mania study: prediction of recovery and first recurrence","volume":"160","author":"Tohen","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.06.023_bb0340","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.08m04726","article-title":"Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: a pilot randomized clinical trial","volume":"70","author":"Tramontina","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.06.023_bb0345","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"Vancampfort","year":"2015","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0350","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2017.06.023_bb0360","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.06.023_bb0365","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0b013e3181f15849","article-title":"Treatment options for bipolar depression: a systematic review of randomized, controlled trials","volume":"30","author":"Vieta","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.06.023_bb0370","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2017.06.023_bb0375","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hup.1240","article-title":"Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial","volume":"26","author":"Woo","year":"2011","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.06.023_bb0380","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1399-5618.2004.00134.x","article-title":"Quality of life in patients with bipolar I depression: data from 920 patients","volume":"6","author":"Yatham","year":"2004","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0390","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.06.023_bb0395","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0033291714001305","article-title":"A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania","volume":"45","author":"Yildiz","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2017.06.023_bb0400","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.06.023_bb0405","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"Br. J. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617302385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617302385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:30:10Z","timestamp":1692851410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617302385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":81,"alternative-id":["S0278584617302385"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.023","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}